骨髓抑制,myelosuppression
1)myelosuppression骨髓抑制
1.Abdominal pain,diarrhea andmyelosuppression caused by oral methotrexate;口服甲氨蝶呤引起腹痛、腹泻及骨髓抑制
2.Pufferfish type Ⅰ collagen extract prevented and curedmyelosuppression induced by cyclophosphamide or diamminedichloroplatinum or cytosine arabinoside in mice;河鲀Ⅰ型胶原蛋白提取物防治环磷酰胺、顺铂或阿糖胞苷诱发小鼠骨髓抑制的研究
3.35 Cases with AIDS Complicating Myelosuppression after HAART in the Jingyuankang Capsule;精元康胶囊对艾滋病HAART疗法致骨髓抑制35例的临床观察
英文短句/例句
1.The main toxicities were myelotoxicity and phlebitis.主要毒副反应为骨髓抑制和静脉炎。
2.Research Progress on the Effect of Hematinic Chinese Medicine on Resisting Myelosuppression补血中药抗骨髓抑制作用的研究进展
3.Prevention on infection for myelosuppression stage of bone tumors patients accepting high-dose chemotherapy骨肿瘤病人大剂量化疗骨髓抑制期感染的预防
4.The Effect of Jing Yuan Kang Capsule on Suppression of Bone Marrow Karyocyte Expression of Anti-apoptotic Protein in the Bone Marrow of Mice精元康胶囊对骨髓抑制小鼠骨髓有核细胞表达抗凋亡蛋白的影响
5.The Effect of You Gui Wan on Bone Marrow Cell Cycle and Apoptosis of Myelosuppressed Mice右归丸对骨髓抑制小鼠骨髓细胞周期和凋亡的影响
6.No irreversible bone marrow depression and liver function injury was found.未发现不可逆骨髓抑制现象及肝功能受损。
7.Grade 1 or 2 hematopoietic tox icity was observed in 58% of patients and grade 3 in 8%.1 +2级急性骨髓抑制发生率为 58% ,3级为 8%。
8.Clinical Study on Preventing and Controlling Marrow Suppresses by Using "Pi Shen Fang" Conbined with Chemotherapy;“脾肾方”配合化疗防治骨髓抑制的临床观察
9.The Clinical Study of the Effect of Electro-acupuncture in Preventing and Treating Bone Marrow Inhibition Caused by Chemotherapy;电针防治恶性肿瘤化疗后骨髓抑制的临床研究
10.The Experimental Study on the Hematopoietic Regulation of Myelosuppressed Mice with TYY调营饮对骨髓抑制小鼠造血调控的实验研究
11.Malignant Bone Marrow Suppression after Chemotherapy Period of Application of Sterile Care Beds恶性肿瘤化疗后骨髓抑制期应用无菌床的护理
12.Ridge Regression Study of Restrainment of Bone Marrow in Cancer Patients with Chemotherapy Regimens and Antitumor Drugs抗肿瘤药与化疗患者骨髓抑制多元岭回归分析
13.Effect of Zuogui pill on hematopoietic regulation of myelosuppressed mice左归丸对骨髓抑制小鼠造血调控的影响
14.Effect of Yougui Pill on hematopoitetic regulation in myelosuppressed mice右归丸对骨髓抑制小鼠造血功能的影响
15.Clinical and Experimental Study on Treating Bone Marrow Depression Caused by Caused by Chemotherapy with LANTENGYISUITANG;蓝藤益髓汤恢复化疗后骨髓抑制的临床和实验研究
16.Improvation of Ginsenosides Rg_1 on Bone Marrow Function and Mechanism in Bone Marrow Depression Mice by Cyclophosphamide人参皂苷Rg1对环磷酰胺诱导骨髓抑制小鼠骨髓功能的改善及机制研究
17.Effect of formula granule of Siwu on LN,FN,FAK of BMSC in bone marrow depression mice四物汤配方颗粒对骨髓抑制小鼠骨髓基质细胞某些物质表达的影响
18.Study about Hematopoietic Regulation and Its Mechanisms of GuiPi-Pill on Myelosuppressed Mice归脾丸对骨髓抑制小鼠造血调控的影响及机制探讨
相关短句/例句
Bone marrow suppression骨髓抑制
1.Response of rhG-CSF (Rui Xuexin) in treating bone marrow suppression after concurrent chemotherapy puls radiotherapy;瑞血新对同步放化疗后骨髓抑制的作用
2.Treatment status of bone marrow suppression with cytokine;生物因子治疗骨髓抑制的研究进展
3.Severe bone marrow suppression after liver transplantation:a report of 6 cases;肝移植术后并发严重骨髓抑制(附6例报告)
3)Bone marrow depression骨髓抑制
1.The effects of Thyrosin on prevention and treatment of bone marrow depression caused by chemotherapy in malignancies;胸腺肽对肿瘤化疗病人骨髓抑制的防治作用
2.Objective:To observe the effect of Tianjingchongsui Prescription (TP, 填 精 充 髓 方 ) on preventing bone marrow depression caused by chemotherapy.目的观察自拟填精充髓方预防恶性肿瘤化疗患者骨髓抑制的疗效。
3.The author here presented her theoretical and primary clinical studies on the chemotherapy- followed bone marrow depression.本文综述了近十年来中医药治疗化疗后骨髓抑制的研究现状及进展,并系统的探讨了中西医对恶性肿瘤化疗后骨髓抑制的病因病机、治法方药。
4)Bone marrow inhibition骨髓抑制
1.Objective: To observe the curative effect of Guilu Erxian Dan (GED) for bone marrow inhibition (BMI) in mammary cancer after chemotherapy.目的:观察龟鹿二仙丹加味对乳腺癌化疗后骨髓抑制的治疗作用。
5)Marrow Inhibition骨髓抑制
1.Effects of Smoke and Tea on Radiation-induced Bone Marrow Cell Mutation andMarrow Inhibition.;烟、茶对放射线所致骨髓细胞突变和骨髓抑制的影响
2.The efficacy of preventing and curing marrow inhibition induced by chemothorapy by using Hemarisin;惠若舒防治恶性肿瘤化疗所致骨髓抑制的临床疗效研究
6)myelosuppressive骨髓抑制的
延伸阅读
骨髓抑制骨髓抑制指药物引起的造血功能障碍。除甾体类激素、博莱霉素、长春碱类、抗癌锑、L-门冬酰胺酶等极少数抗肿瘤药物外，绝大多数抗癌药都有不同程度的骨髓抑制。其中，影响最大的是白细胞，特别是粒细胞减少最为严重，淋巴细胞受害较轻。随着用药剂量的增加，血液中三系成分均可受到影响，可出现血小板下降，严重时红细胞和血红蛋白也下降，甚至发生再生障碍性贫血。预防：①严格掌握化疗适应证；②化疗期间给与必要的支持疗法；③化疗前白细胞＞4×109/L(4000/mm3)，血小板＞10万/dl，血红蛋白＞4×109/L(10g/dl)。④化疗期间应隔日查血象1次，如白细胞＜4×109/L(4000/mm3)或血小板＜10万/dl，停药观察1天，如连续3天白细胞血小板未上升到上述标准，则应停药结束此疗程，待血象恢复后再开始新疗程。⑤白细胞＜1×109/L(1000/mm3)时，病人应迁入无菌隔离室，以免发生感染；白细胞＜5×109/L(500/mm3)时，或病人出现感染征象时，应予抗生素预防感染，并给少量多次新鲜血，刺激骨髓，增强抵抗力。血小板＜20/L(2万/dl)或出现出血体征时，应给予止血药，输新鲜血或血小板。⑥集落刺激因子的应用。⑦临床上很少因化疗造成严重贫血，只有铂化合物有可能引起严重贫血而需输血。
